It was reported that toxic anterior segment syndrome (tass) occurred in the left eye of a patient which was implanted with an intraocular lens.Moxifloxacin ophthalmic eye drops were given as a normal pre and post regimen.The patient was also taking durezol eye drops every 1-2 hours.In addition, the patient was given a medrol dose pak 4mg tablets po (use as directed) on (b)(6) 2020 post surgery.It was noted that the patient has recovered.The lens remains in the patient's eye.The account indicated that they have been doing an investigation and at this point they do not know where the tass is coming from.No further information was provided.This emdr report is for the healon endocoat device.A separate emdr will be submitted for the intraocular lens, model zcu450.
|
Additional information/corrected data: additional information received indicated that the post-op drops given to the patient were moxifloxacin, ketorolac, prednisolone.Also, initially the account reported ''(b)(6) 1950'' to be the date of birth for the patient which was entered in the initial emdr report.However, additional information received from the account clarified that the correct date of birth for the patient is ''(b)(6) 1950''.Therefore the following field was updated accordingly: section a2: age/date of birth: (b)(6) 1950.Upon further review of the complaint file, it was noted that the event reported for the healon endocoat product, lot 028612 under the manufacturer #3004750704-2020-00075 was a duplicate of an earlier event which had already been reported under the manufacturer report #3004750704-2020-00054.Therefore, no further information will be provided under this medwatch #3004750704-2020-00075 as it has now been determined to be a duplicate report.All pertinent information available to johnson and johnson surgical vision, inc.Has been submitted.
|